New cancer treatment linked to increased risk of recurrence FDA: New cancer treatment increases risk of secondary cancer

No time to read?
Get a summary

A relatively new cancer treatment known as CAR T cell therapy is dangerous. reported At the US Food and Drug Administration (FDA). Researchers found evidence that the treatment could potentially increase the risk of secondary cancer. But the FDA still says the positives of CAR T therapy outweigh the potential negatives.

CAR-T cell therapy is a method to treat cancer patients using immune T cells that are previously taken from the body, specially prepared, and reintroduced into the blood as medicine. This treatment is currently approved only for certain types of blood cancer and has been shown to be particularly effective in cases once thought to be incurable. Researchers continue to develop more versatile forms of CAR T and may even have potential in treating autoimmune diseases such as lupus.

However, advanced T cells can release excess chemicals called cytokines that systematically damage the body, causing serious, even fatal complications, including the development of secondary cancers.

CAR-T is generally used as a last resort; This means that patients taking it already have a high risk of dying from cancer. Therefore, even the already established risks of this treatment will not force medical organizations to refuse to continue treatment.

Previous scientists discovered The connection between breathing during sleep and memory.

No time to read?
Get a summary
Previous Article

The court fined Josep Maria Mainat 500 euros for not attending his ex-wife’s trial

Next Article

Hate session in the Sejm! Tusk uses disabled people to attack PiS: you have time to take criminals to greater heights